midodrine hydrochloride (Bramox)

The SMC has accepted for use in NHS Scotland, midodrine (Bramox) for severe orthostatic hypotension due to autonomic dysfunction when corrective factors have been ruled out and other forms of treatment are inadequate.

Bramox 5mg tablets have been shown to be bioequivalent to the unlicensed midodrine 5mg product currently in use in NHS Scotland and will allow the prescribing of a licensed medicinal product, with a resultant small net budget impact.